| Literature DB >> 25923890 |
Lara Stefânia Netto de Oliveira Leão-Vasconcelos1, Ana Beatriz Mori Lima2, Dayane de Melo Costa3, Larissa Oliveira Rocha-Vilefort3, Ana Claúdia Alves de Oliveira4, Nádia Ferreira Gonçalves5, José Daniel Gonçalves Vieira1, Marinésia Aparecida Prado-Palos3.
Abstract
The evaluation of workers as potential reservoirs and disseminators of pathogenic bacteria has been described as a strategy for the prevention and control of healthcare-associated infections (HAIs). The aim of this study was to evaluate the presence of Enterobacteriaceae in the oral cavity of workers at an oncology hospital in the Midwest region of Brazil, as well as to characterize the phenotypic profile of the isolates. Saliva samples of 294 workers from the hospital's healthcare and support teams were collected. Microbiological procedures were performed according to standard techniques. Among the participants, 55 (18.7%) were colonized by Enterobacteriaceae in the oral cavity. A total of 64 bacteria were isolated, including potentially pathogenic species. The most prevalent species was Enterobacter gergoviae (17.2%). The highest rates of resistance were observed for β-lactams, and 48.4% of the isolates were considered multiresistant. Regarding the enterobacteria isolated, the production of ESBL and KPC was negative. Nevertheless, among the 43 isolates of the CESP group, 51.2% were considered AmpC β-lactamase producers by induction, and 48.8% were hyper-producing mutants. The significant prevalence of carriers of Enterobacteriaceae and the phenotypic profile of the isolates represents a concern, especially due to the multiresistance and production of AmpC β-lactamases.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25923890 PMCID: PMC4435009 DOI: 10.1590/S0036-46652015000200004
Source DB: PubMed Journal: Rev Inst Med Trop Sao Paulo ISSN: 0036-4665 Impact factor: 1.846
Species of Enterobacteriaceae (n = 64) isolated from the oral cavity of workers in an oncology hospital. Goiania, Goias, 2009-2010
| Microorganism | Isolates (f) | Total (%) |
|---|---|---|
|
| 11 | 17.2 |
|
| 08 | 12.5 |
|
| 08 | 12.5 |
|
| 08 | 12.5 |
|
| 07 | 10.9 |
|
| 05 | 7.8 |
|
| 04 | 6.2 |
|
| 04 | 6.2 |
|
| 03 | 4.7 |
|
| 02 | 3.1 |
|
| 02 | 3.1 |
|
| 02 | 3.1 |
|
| 64 | 100 |
Profile of antimicrobial susceptibility of Enterobacteriaceae (n = 64) isolates from the oral cavity of workers in an oncology hospital. Goiania, Goias, 2009-2010
| Antimicrobial Agent | S | I | R | Total R |
|---|---|---|---|---|
| Isolates (f) | (%) | |||
| Amoxicillin-clavulanic acid | 18 | 9 | 37 | 57.8 |
| Cefoxitin | 35 | 0 | 29 | 45.3 |
| Tetracycline | 53 | 1 | 10 | 15.6 |
| Cefpodoxime | 49 | 8 | 7 | 10.9 |
| Trimetoprim-sulfmetoxazol | 61 | 1 | 2 | 3.1 |
| Ceftazidime | 63 | 0 | 1 | 1.6 |
| Ceftriaxone | 63 | 0 | 1 | 1.6 |
| Piperacillin tazobactam | 63 | 0 | 1 | 1.6 |
| Cefotaxime | 63 | 1 | 0 | 0 |
| Aztreonam | 63 | 1 | 0 | 0 |
| Cefepime | 64 | 0 | 0 | 0 |
| Ciprofloxacin | 64 | 0 | 0 | 0 |
| Gentamicin | 64 | 0 | 0 | 0 |
| Imipenem | 64 | 0 | 0 | 0 |
| Levofloxacin | 64 | 0 | 0 | 0 |
| Meropenem | 64 | 0 | 0 | 0 |
β-lactamases produced by Enterobacteriaceae (n = 64) isolated from the oral cavity of workers in an oncology hospital. Goiania, Goias, 2009-2010
| Enzymes | Isolates evaluated | Positive isolates | Total |
|---|---|---|---|
| (f) | (f) | (%) | |
| KPC | 64 | 0 | 0 |
| AmpC/induction | 43 | 22 | 51.2 |
| AmpC/hyperproduction | 43 | 21 | 48.8 |
| ESBL | 16 | 0 | 0 |
KPC: Klebsiella pneumoniae Carbapenemase; ESBL: Extended Spectrum β-lactamase.